omega-n-methylarginine has been researched along with Left Ventricular Dysfunction in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abel, ED; Hu, P; Litwin, SE; Sena, S; Sloan, CL; Symons, JD; Wang, X; Wende, AR; Yang, Y; Zhang, QJ | 1 |
| Mak, S; Newton, GE; Overgaard, CB | 1 |
| Fang, Q; Finkel, MS; Jain, AC; Kan, H; Khanna, D; Underwood, BL; Williams, HJ; Xie, Z | 1 |
| Colucci, WS; Creager, MA; Hare, JM; Loh, E | 1 |
| Hori, M; Kamada, T; Kondo, H; Mano, T; Masuyama, T; Nagano, R; Naito, J; Tanouchi, J; Yamamoto, K | 1 |
| Hori, M; Kamada, T; Kondo, H; Mano, T; Masuyama, T; Nagano, R; Naito, J; Yamamoto, K | 1 |
| Colucci, WS; Creager, MA; Givertz, MM; Hare, JM | 1 |
| Banks, SM; Cobb, JP; Cunnion, RE; Danner, RL; Eichacker, PQ; Freeman, BD; Karzai, W; Natanson, C; Quezado, MJ; Quezado, ZM; Sevransky, JE; Yan, L | 1 |
| Fetics, B; Hare, JM; Kass, DA; Maughan, WL; Pak, PH; Wittstein, IS | 1 |
1 trial(s) available for omega-n-methylarginine and Left Ventricular Dysfunction
| Article | Year |
|---|---|
Effect of vitamin C and L-NMMA on the inotropic response to dobutamine in patients with heart failure.
Topics: Ascorbic Acid; Blood Pressure; Cardiotonic Agents; Dobutamine; Drug Combinations; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Myocardial Contraction; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Treatment Outcome; Ventricular Dysfunction, Left | 2005 |
8 other study(ies) available for omega-n-methylarginine and Left Ventricular Dysfunction
| Article | Year |
|---|---|
Knockout of insulin receptors in cardiomyocytes attenuates coronary arterial dysfunction induced by pressure overload.
Topics: Acetylcholine; Analysis of Variance; Animals; Blotting, Western; Coronary Vessels; Echocardiography; Genotype; Hypertrophy, Left Ventricular; Male; Mice; Mice, Knockout; Myocytes, Cardiac; Nitroprusside; omega-N-Methylarginine; Receptor, Insulin; Reverse Transcriptase Polymerase Chain Reaction; Ventricular Dysfunction, Left | 2011 |
Inducible nitric oxide synthase attenuates adrenergic signaling in alcohol fed rats.
Topics: Administration, Oral; Adrenergic beta-Agonists; Animals; Blotting, Western; Caloric Restriction; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Ethanol; Isoproterenol; Male; Myocardial Contraction; Myocytes, Cardiac; Nitric Oxide Synthase Type II; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley; Signal Transduction; Time Factors; Ventricular Dysfunction, Left; Ventricular Pressure | 2007 |
Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunction.
Topics: Adrenergic beta-Agonists; Arginine; Dobutamine; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Myocardial Contraction; Myocardium; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Stimulation, Chemical; Ventricular Dysfunction, Left | 1995 |
Basal release of endothelium-derived nitric oxide plays an important role in the prevention of afterload mismatch in acute left ventricular dysfunction.
Topics: Acute Disease; Analysis of Variance; Animals; Arginine; Blood Pressure Determination; Coronary Thrombosis; Dogs; Echocardiography; Endothelium, Vascular; Enzyme Inhibitors; Hemodynamics; Microspheres; Nitric Oxide; omega-N-Methylarginine; Time Factors; Ventricular Dysfunction, Left | 1995 |
Role of basal release of nitric oxide in the presence of acute left ventricular dysfunction: comparative study with normal condition.
Topics: Acetylcholine; Acute Disease; Animals; Arginine; Blood Flow Velocity; Dogs; Enzyme Inhibitors; Femoral Artery; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Random Allocation; Ventricular Dysfunction, Left; Ventricular Function, Left | 1996 |
Increased sensitivity to nitric oxide synthase inhibition in patients with heart failure: potentiation of beta-adrenergic inotropic responsiveness.
Topics: Acetylcholine; Adrenergic beta-Agonists; Cardiomyopathy, Dilated; Dobutamine; Drug Synergism; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Nitric Oxide Synthase; omega-N-Methylarginine; Ventricular Dysfunction, Left | 1998 |
Effects of L-NMMA and fluid loading on TNF-induced cardiovascular dysfunction in dogs.
Topics: Animals; Dogs; Enzyme Inhibitors; Hemodynamics; Hypotension; Infusions, Intravenous; Isotonic Solutions; omega-N-Methylarginine; Pulmonary Wedge Pressure; Ringer's Solution; Tumor Necrosis Factor-alpha; Venous Pressure; Ventricular Dysfunction, Left; Water-Electrolyte Balance | 1998 |
Cardiac nitric oxide production due to angiotensin-converting enzyme inhibition decreases beta-adrenergic myocardial contractility in patients with dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cardiomyopathy, Dilated; Compliance; Depression, Chemical; Diastole; Dobutamine; Enalaprilat; Enzyme Inhibitors; Female; Heart; Hemodynamics; Humans; Losartan; Male; Middle Aged; Myocardial Contraction; Myocardium; Nitric Oxide; omega-N-Methylarginine; Ventricular Dysfunction, Left | 2001 |